![]() |
|
|
Molecular Pharmacology, Vol 13, 615-620, Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics
1 Mid-Atlantic Research Institute, Bethesda, Maryland 20014
2 Microanalytical Services and Instrumentation Section, Laboratory of Chemistry, National Institute of
Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014
The interaction between 31P-containing substrates, 4-deoxypyridoxine phosphate and
monomethyl phosphate, and a series of protonated biogenic amines has been quantitated by use of [31P]-1H nuclear magnetic double resonance and titration. The difference
in the phosphorus chemical shifts with and without amine in deuterated water indicated
that optimal biogenic amine-phosphate interaction appears to require the presence of
both a catechol ring and a
-hydroxyl group in the ethylamine side chain. This is in good
agreement with pharmacological measurements in vitro of biogenic amine retention by
storage vesicles of rat heart adrenergic nerve terminals, indicating that phosphate could
be involved in binding of biogenic amines in these vesicles. The model in vitro presented
could provide a rapid, efficient method for biological evaluation of various drug-receptor
systems involving phosphate-amine interactions.
Note:
ACKNOWLEDGMENTS
We thank Drs. C. R. Creveling, J. Daly, and I.
Kopin for useful comments and discussions, and
Mrs. L. Weber and S. Paper for their assistance in
manuscript preparation.